Omeprazole/Ketoprofen

奥美拉唑/酮洛芬

Report date: 2023/04/21 09:52:30

Base Information

Drug NameOmeprazole/Ketoprofen
Drug Alias Name奥美拉唑/酮洛芬omeprazole and ketoprofen酮洛芬+奥美拉唑Omeprazole/Ketoprofenketoprofen and omeprazole +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProton pump inhibitorsCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors +[4] 
TargetsProton pumpCyclooxygenase-2Cyclooxygenase-1 +[4] 
Therapy Area/IndicationsOsteoarthritisArthritis, RheumatoidSpondylitis, Ankylosing
Global Approved IndicationsOsteoarthritisArthritis, RheumatoidSpondylitis, Ankylosing
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date2008/12/01
Country/TerritoryUnited Kingdom
CombinationsYes OmeprazoleKetoprofen
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active CompaniesMeda Ab
Inactive CompaniesN/A
Active IndicationsOsteoarthritisArthritis, RheumatoidSpondylitis, Ankylosing
Inactive IndicationsN/A

Other Information

ATC CodeA02BC01
Related LinksN/A